Literature DB >> 10456963

Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria.

D J Perkins1, P G Kremsner, D Schmid, M A Misukonis, M A Kelly, J B Weinberg.   

Abstract

Plasmodium falciparum malaria is an important cause of morbidity and mortality in children. Factors that determine the development of mild versus severe malaria are not fully understood. Since host-derived nitric oxide (NO) has antiplasmodial properties, we measured NO production and NO synthase (NOS) activity in peripheral blood mononuclear cells (PBMC) from healthy Gabonese children with a history of prior mild malaria (PMM) or prior severe malaria (PSM) caused by P. falciparum. The PMM group had significantly higher levels of NOS activity in freshly isolated PBMC and higher NO production and NOS activity in cultured PBMC. The investigation of NO-modulating cytokines (e.g., interleukin 12, gamma interferon, tumor necrosis factor alpha [TNF-alpha], and transforming growth factor beta1) as an explanation for differing levels of NOS activity revealed that plasma levels of TNF-alpha were significantly higher in the PSM group. Our results suggest that NOS/ NO and TNF-alpha are markers for prior disease severity and important determinants of resistance to malaria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456963      PMCID: PMC96841     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Killing of Plasmodium falciparum in vitro by nitric oxide derivatives.

Authors:  K A Rockett; M M Awburn; W B Cowden; I A Clark
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.

Authors:  P Kern; C J Hemmer; J Van Damme; H J Gruss; M Dietrich
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

3.  Anti-TNF therapy inhibits fever in cerebral malaria.

Authors:  D Kwiatkowski; M E Molyneux; S Stephens; N Curtis; N Klein; P Pointaire; M Smit; R Allan; D R Brewster; G E Grau
Journal:  Q J Med       Date:  1993-02

4.  Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine.

Authors:  P G Kremsner; S Neifer; M F Chaves; R Rudolph; U Bienzle
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

5.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

6.  L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation.

Authors:  A Nüssler; J C Drapier; L Rénia; S Pied; F Miltgen; M Gentilini; D Mazier
Journal:  Eur J Immunol       Date:  1991-01       Impact factor: 5.532

7.  Urinary nitrate excretion in relation to murine macrophage activation. Influence of dietary L-arginine and oral NG-monomethyl-L-arginine.

Authors:  D L Granger; J B Hibbs; L M Broadnax
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

8.  Tumor necrosis factor and disease severity in children with falciparum malaria.

Authors:  G E Grau; T E Taylor; M E Molyneux; J J Wirima; P Vassalli; M Hommel; P H Lambert
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

9.  Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.

Authors:  Y Vodovotz; C Bogdan; J Paik; Q W Xie; C Nathan
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.

Authors:  J B Weinberg; D L Granger; D S Pisetsky; M F Seldin; M A Misukonis; S N Mason; A M Pippen; P Ruiz; E R Wood; G S Gilkeson
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 2.  Nitric oxide and redox mechanisms in the immune response.

Authors:  David A Wink; Harry B Hines; Robert Y S Cheng; Christopher H Switzer; Wilmarie Flores-Santana; Michael P Vitek; Lisa A Ridnour; Carol A Colton
Journal:  J Leukoc Biol       Date:  2011-01-13       Impact factor: 4.962

3.  Low interleukin-12 activity in severe Plasmodium falciparum malaria.

Authors:  A J Luty; D J Perkins; B Lell; R Schmidt-Ott; L G Lehman; D Luckner; B Greve; P Matousek; K Herbich; D Schmid; J B Weinberg; P G Kremsner
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Involvement of Nod2 in the innate immune response elicited by malarial pigment hemozoin.

Authors:  Yolanda Corbett; Silvia Parapini; Sarah D'Alessandro; Diletta Scaccabarozzi; Bruno C Rocha; Timothy J Egan; Aneesa Omar; Laura Galastri; Katherine A Fitzgerald; Douglas T Golenbock; Donatella Taramelli; Nicoletta Basilico
Journal:  Microbes Infect       Date:  2014-11-21       Impact factor: 2.700

5.  Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells.

Authors:  Christopher C Keller; Peter G Kremsner; James B Hittner; Mary A Misukonis; J Brice Weinberg; Douglas J Perkins
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Plasma interleukin-12 in malaria-tolerant papua new guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity.

Authors:  Craig S Boutlis; Moses Lagog; Sujittra Chaisavaneeyakorn; Mary A Misukonis; Moses J Bockarie; Charles S Mgone; Zhiqiang Wang; Grant Morahan; J Brice Weinberg; Venkatachalam Udhayakumar; Nicholas M Anstey
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Authors:  Marc C Levesque; Maurine R Hobbs; Charles W O'Loughlin; Jennifer A Chancellor; Youwei Chen; Ariana N Tkachuk; Jennifer Booth; Kistie B Patch; Sallie Allgood; Ann R Pole; Carolyn A Fernandez; Esther D Mwaikambo; Theonest K Mutabingwa; Michal Fried; Bess Sorensen; Patrick E Duffy; Donald L Granger; Nicholas M Anstey; J Brice Weinberg
Journal:  Hum Genet       Date:  2009-10-27       Impact factor: 4.132

8.  Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults.

Authors:  Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Mary A Misukonis; Jocelyn R Saunders; Sri Suprianto; J Brice Weinberg; Nicholas M Anstey
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria.

Authors:  Joe Brice Weinberg; Tsin W Yeo; Jackson P Mukemba; Salvatore M Florence; Alicia D Volkheimer; Hao Wang; Youwei Chen; Matthew Rubach; Donald L Granger; Esther D Mwaikambo; Nicholas M Anstey
Journal:  J Infect Dis       Date:  2014-03-11       Impact factor: 5.226

Review 10.  Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria.

Authors:  J Brice Weinberg; Bert K Lopansri; Esther Mwaikambo; Donald L Granger
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.